RAD 2025: Jiade Yu, MD, discussed chronic hand eczema as a distinct condition from AD, highlighting its clinical burden and emerging treatments, such as delgocitinib.
At RAD 2025, Jiade Yu, MD, delivered a compelling presentation on the complexities of chronic hand eczema (CHE)—an often mischaracterized condition that extends well beyond atopic dermatitis. In this interview with Patient Care, Yu explains why CHE should be viewed as a collection of distinct dermatologic conditions, discusses the social and occupational burden it imposes, and previews emerging therapies that could soon transform treatment. He also shares what he hopes clinicians will take away from his talk, including the need for tailored approaches and greater disease recognition.
Atopic Dermatitis: The Pipeline and Clinical Approaches That Could Transform the Standard of Care
September 24th 2025Patient Care tapped the rich trove of research and expert perspective from the 2025 Revolutionizing Atopic Dermatitis meeting to create a snapshot of the AD care of the future.